Blood Res.  2016 Dec;51(4):281-285. 10.5045/br.2016.51.4.281.

Toxic megacolon and interstitial pneumonia caused by cytomegalovirus infection in a pediatric patient with acute lymphoblastic leukemia receiving chemotherapy

• Kwon H
• Lee HH
• Paik CR
• Lim YJ
• Park JA

• KMID: 2364321
• DOI: http://doi.org/10.5045/br.2016.51.4.281

Abstract

No abstract available.

MeSH Terms

Cytomegalovirus Infections*
Cytomegalovirus*
Drug Therapy*
Humans
Lung Diseases, Interstitial*
Megacolon, Toxic*
Precursor Cell Lymphoblastic Leukemia-Lymphoma*

Figure

• 

  Fig. 1 The patient developed fever, dyspnea, and abdominal distension on day 28 of induction. Chest X-ray (A) showed a newly developed pneumonic consolidation. Abdominal X-ray (B) showed a gas-filled colonic dilatation resembling toxic megacolon. A high-resolution computed tomography (HRCT; C, D) demonstrated the development of consolidations and ground-glass opacities in both lung fields.

• 

  Fig. 2 Sigmoidoscopy performed on day 40 revealed active bleeding with multiple hemorrhagic ulcers throughout the colon (A). Endoscopic biopsy revealed a chronic inflammatory ulcer (B). Histopathologic staining did not show any inclusion-bearing cells typical of CMV infection (owl's eye inclusions); however, immunohistochemical staining identified immunoreactivity for CMV antigen (C).

• 

  Fig. 3 Serial chest X-rays on day 54 showed progressive haziness in both lungs despite 2 weeks of ganciclovir treatment (A). Chest CT (B) on the same day (day 54) showed increased multifocal patchy consolidations and ground-glass opacities in both lung fields compared with previous chest CT images.

Reference

1. Ng AP, Worth L, Chen L, et al. Cytomegalovirus DNAemia and disease: incidence, natural history and management in settings other than allogeneic stem cell transplantation. Haematologica. 2005; 90:1672–1679. PMID: 16330442.

2. Osawa R, Singh N. Cytomegalovirus infection in critically ill patients: a systematic review. Crit Care. 2009; 13:R68. PMID: 19442306.

3. Torres HA, Aguilera E, Safdar A, et al. Fatal cytomegalovirus pneumonia in patients with haematological malignancies: an autopsy-based case-control study. Clin Microbiol Infect. 2008; 14:1160–1166. PMID: 19046167.

4. Mitchell HR, Lu X, Myers RM, et al. Prospective, longitudinal assessment of quality of life in children from diagnosis to 3 months off treatment for standard risk acute lymphoblastic leukemia: Results of Children's Oncology Group study AALL0331. Int J Cancer. 2016; 138:332–339. PMID: 26235006.

5. Jaber S, Chanques G, Borry J, et al. Cytomegalovirus infection in critically ill patients: associated factors and consequences. Chest. 2005; 127:233–241. PMID: 15653989.

6. Torres HA, Kontoyiannis DP, Bodey GP, et al. Gastrointestinal cytomegalovirus disease in patients with cancer: a two decade experience in a tertiary care cancer center. Eur J Cancer. 2005; 41:2268–2279. PMID: 16143517.

7. Cook CH, Zhang Y, McGuinness BJ, Lahm MC, Sedmak DD, Ferguson RM. Intra-abdominal bacterial infection reactivates latent pulmonary cytomegalovirus in immunocompetent mice. J Infect Dis. 2002; 185:1395–1400. PMID: 11992273.

8. Gondo H, Minematsu T, Harada M, et al. Cytomegalovirus (CMV) antigenaemia for rapid diagnosis and monitoring of CMV-associated disease after bone marrow transplantation. Br J Haematol. 1994; 86:130–137. PMID: 8011521.

9. Green ML, Leisenring W, Stachel D, et al. Efficacy of a viral load-based, risk-adapted, preemptive treatment strategy for prevention of cytomegalovirus disease after hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2012; 18:1687–1699. PMID: 22683614.

10. Ruell J, Barnes C, Mutton K, et al. Active CMV disease does not always correlate with viral load detection. Bone Marrow Transplant. 2007; 40:55–61. PMID: 17468776.

11. Kim JW, Boo SJ, Ye BD, et al. Clinical utility of cytomegalovirus antigenemia assay and blood cytomegalovirus DNA PCR for cytomegaloviral colitis patients with moderate to severe ulcerative colitis. J Crohns Colitis. 2014; 8:693–701. PMID: 24405983.

12. Hantz S, Garnier-Geoffroy F, Mazeron MC, et al. Drug-resistant cytomegalovirus in transplant recipients: a French cohort study. J Antimicrob Chemother. 2010; 65:2628–2640. PMID: 20961907.

13. Shmueli E, Or R, Shapira MY, et al. High rate of cytomegalovirus drug resistance among patients receiving preemptive antiviral treatment after haploidentical stem cell transplantation. J Infect Dis. 2014; 209:557–561. PMID: 23983215.

14. Le Page AK, Jager MM, Iwasenko JM, Scott GM, Alain S, Rawlinson WD. Clinical aspects of cytomegalovirus antiviral resistance in solid organ transplant recipients. Clin Infect Dis. 2013; 56:1018–1029. PMID: 23243176.